Risk stratification in diffuse large B cell lymphoma using lesion dissemination and metabolic tumor burden calculated from baseline PET/CT.
Fiche publication
Date publication
décembre 2020
Journal
Annals of oncology : official journal of the European Society for Medical Oncology
Auteurs
Membres identifiés du Cancéropôle Est :
Dr CASASNOVAS Olivier
Tous les auteurs :
Cottereau AS, Meignan M, Nioche C, Capobianco N, Clerc J, Chartier L, Vercellino L, Casasnovas O, Thieblemont C, Buvat I
Lien Pubmed
Résumé
We analysed the prognostic value of a new baseline PET parameter reflecting the spread of the disease, the largest distance between two lesions (Dmax). We tested its complementarity to metabolic tumor volume (MTV) in a large cohort of diffuse large B cell lymphoma (DLBCL) patients from the REMARC trial (NCT01122472).
Mots clés
DLBCL, lesion dissemination- metabolic tumor volume- PET/CT
Référence
Ann Oncol. 2020 Dec 2;: